January 30, 2015 5:23 PM ET

Healthcare Equipment and Supplies

Company Overview of Neogenix LLC

Company Overview

Neogenix LLC, doing business as Ogenix, designs, markets, and sells a line of medical devices that are used for treatment of various wounds. The company offers EPIFLO, a transdermal continuous oxygen therapy, which treats various chronic wounds, such as diabetic foot ulcers, venous leg ulcers and venous stasis, pressure sores or bed sores (decubitus), surgical wounds, burns, infections, and others. Its device is available through doctors, hospitals, clinics, skilled nursing facilities, and direct. Neogenix LLC was founded in 1995 and is based in Ft. Lauderdale, Florida.

2001 SW 20th Street

Suite 102

Ft. Lauderdale, FL 33315

United States

Founded in 1995

Phone:

561-300-4001

Fax:

561-910-0910

Key Executives for Neogenix LLC

President and Director
Managing Director
Chief Technology Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
DentLight, Inc. United States
Jeneric/Pentron Incorporated United States
Oxus Medical, Inc. United States
HemoCue, Inc. United States
Touch Scientific, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
November 5, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neogenix LLC, please visit www.ogenix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.